SCHEMBL5223581

SCHEMBL5223581

COC(=O)c1cc(N2CCCCS2(=O)=O)c(OC)c([N+](=O)[O-])c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
TPMT P51580 1/20 0.43
MAPT P10636 5/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
VCAM1 P19320 1/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
OPRK1 P41145 1/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 1/20 0.40
WDR5 P61964 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5217410 0.97 MEN1 (0.43) KMT2AMEN1TPMTMAPTCYP1A2
SCHEMBL5223575 0.89 TPMT (0.43) KMT2AMEN1TPMTMAPTCYP1A2
SCHEMBL5220082 0.88 MEN1 (0.43) KMT2AMEN1MAPTCYP1A2CYP2D6
SCHEMBL5224653 0.84 MEN1 (0.44) KMT2AMEN1MAPTCYP1A2CYP2D6
SCHEMBL5221138 0.82 KDM4E (0.49) MAPTALDH1A1HPGDGAAKDM4E
SCHEMBL5220771 0.80 ALDH1A1 (0.42) KMT2AMEN1MAPTALDH1A1OPRK1
SCHEMBL5220487 0.78 KDM4E (0.47) MAPTALDH1A1HPGDGAAKDM4E
SCHEMBL5218051 0.78 BACE1 (0.51) KMT2AMEN1ALDH1A1GAAKDM4E
SCHEMBL5217567 0.78 POLB (0.37) ALDH1A1KDM4ERAB9ASMN1; SMN2POLB
SCHEMBL5217563 0.78 POLB (0.37) ALDH1A1KDM4ERAB9ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed